Avidity Science Acquires Lab Products, Bio Medic Data Systems, Hydropac and Harford Systems

Gen Cap America Acquires Lab Products and Harford Systems from Avidity Science

September 3, 2021

Medical Devices

Gen Cap America, in partnership with existing management, has acquired Lab Products, LLC and Harford Systems, LLC from Avidity Science. Lab Products manufactures laboratory research animal housing, cages, and environmental control systems and is headquartered in Seaford, Delaware with a manufacturing facility in Aberdeen, Maryland. Terms of the transaction were not disclosed.

Avidity Science Acquires Cascada Laboratory Water Purification Product Line from Pall Corporation

May 1, 2020

Medical Devices

Avidity Science, a ShoreView portfolio company, acquired the Cascada Laboratory Water Purification product line from Pall Corporation (a Danaher company). The deal expands Avidity's water purification portfolio and establishes manufacturing and distribution operations in Jiaxing, China to better serve customers in Asia.

ATS Corporation Acquires Avidity Science

September 22, 2023

Medical Devices

ATS Corporation has entered into a definitive agreement to acquire Avidity Science, a designer and manufacturer of automated water purification and delivery systems for biomedical and life science applications, for US$195 million. The acquisition strengthens ATS's life sciences capabilities and is expected to close in Q4 2023 subject to customary regulatory filings.

Avidity Science Acquires Edstrom Japan Ltd.

October 17, 2019

Medical Devices

Avidity Science, a ShoreView portfolio company, has acquired Edstrom Japan Ltd., a Tokyo-based supplier of laboratory equipment, consumables, and services to the Japanese life sciences research market. The acquisition expands Avidity's presence and customer relationships in Japan and is an add-on to the company’s existing platform under ShoreView Industries.

Agilent Technologies Acquires Avida Biomed

January 4, 2023

Biotechnology

Agilent Technologies has acquired Avida Biomed, an early-stage developer of high-performance NGS target enrichment workflows for cancer research. The acquisition augments Agilent's SureSelect portfolio and expands its capabilities into high-growth clinical research and diagnostics markets by adding Avida's chemistries and automatable assays compatible with Agilent platforms.

GHO Capital and Ampersand Acquire Avid Bioservices for $1.1 Billion

November 7, 2024

Biotechnology

GHO Capital Partners and Ampersand Capital Partners have completed the acquisition of Avid Bioservices, a dedicated biologics CDMO, in an all-cash transaction valued at approximately $1.1 billion. The transaction takes Avid private (shareholders received $12.50 per share) and positions the company for capability expansion, geographic reach and accelerated growth under the new PE ownership.